BNP Paribas Financial Markets
ROIV icon

BNP Paribas Financial Markets’s Roivant Sciences ROIV Stock Holding History

BNP Paribas Financial Markets’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.4M Sell
2,073,137
-443,216
-18% -$13.1M 0.03% 580
2026
Q1 		$69.7M Buy
2,516,353
+221,847
+10% +$5.7M 0.03% 538
2025
Q4 		$49.8M Buy
2,294,506
+534,626
+30% +$10.5M 0.02% 688
2025
Q3 		$26.6M Buy
1,759,880
+1,603,535
+1,026% +$19.9M 0.01% 949
2025
Q2 		$1.76M Sell
156,345
-322,410
-67% -$3.49M ﹤0.01% 2562
2025
Q1 		$4.83M Buy
478,755
+10,745
+2% +$116K ﹤0.01% 1836
2024
Q4 		$5.54M Buy
+468,010
New +$5.53M ﹤0.01% 1719
2022
Q4 		– Sell
-15,200
Closed -$48.9K – 4503
2022
Q3 		$48.9K Buy
+15,200
New +$58.9K ﹤0.01% 3987

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BNP Paribas Financial Markets's ROIV Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Roivant Sciences (ROIV) stake by 18% in Q2 2026, selling an estimated $13.1M and leaving 2,073,137 shares worth $73.4M. The position accounts for 0.03% of the portfolio, ranked #580.

BNP Paribas Financial Markets first reported a position in ROIV in Q3 2022 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • BNP Paribas Financial Markets held 2,073,137 shares of Roivant Sciences worth $73.4M as of Q2 2026.
  • BNP Paribas Financial Markets sold 443,216 Roivant Sciences shares in Q2 2026, an estimated $13.1M.
  • Roivant Sciences made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #580 holding.
  • BNP Paribas Financial Markets first reported a position in Roivant Sciences in Q3 2022 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.